Medicine and Dentistry
Action Potential Amplitude
17%
Adolescent
15%
Amyotrophic Lateral Sclerosis
33%
Autonomic Neuropathy
12%
Biological Marker
13%
Chronic Inflammatory Demyelinating Polyneuropathy
19%
Compound Muscle Action Potential
26%
Cross Sectional Study
20%
Diabetes
17%
Diabetes Mellitus
12%
Diabetic Neuropathy
89%
Diagnosis
41%
Diagnosis of Amyotrophic Lateral Sclerosis
16%
Diffusion Tensor Imaging
14%
Disease
11%
Early Diagnosis
13%
Electrodiagnosis
19%
Electromyography
24%
Excitability
17%
Hemoglobin A1c
12%
Immunoglobulin
12%
Insulin Dependent Diabetes Mellitus
23%
Maturity Onset Diabetes of the Young
45%
Motor Neuron Disease
9%
Motor Unit
39%
Motor Unit Number Estimation
50%
Motor Unit Potential
12%
Muscle Fiber Membrane
12%
Myopathy
19%
Nerve Conduction Study
43%
Nerve Excitability
26%
Nerve Fiber
17%
Neuropathic Pain
10%
Neuropathy
60%
Nicotinamide Adenine Dinucleotide
12%
Oxaliplatin
10%
Patient with Type 2 Diabetes
18%
Peripheral Nerve
15%
Peripheral Nervous System
11%
Placebo
13%
Polyneuropathy
88%
Prevalence
13%
Reflex Arc
16%
Refractory Period
9%
Reproducibility
13%
Spinal Cord Injury
27%
Sural Nerve
19%
Symptom
23%
Tibial Nerve
13%
Transcranial Magnetic Stimulation
10%
Neuroscience
Action Potential
35%
Amyotrophic Lateral Sclerosis
52%
Autonomic Neuropathy
11%
Axon
12%
Axonal Excitability
14%
Diabetes Mellitus
12%
Diabetic Neuropathy
83%
Diagnosis of Amyotrophic Lateral Sclerosis
17%
Docetaxel
8%
Electrodiagnosis
20%
Electroencephalography
20%
Electromyography
37%
Electromyography
15%
Excitability
18%
Fractional Anisotropy
7%
Heart Rate Variability
9%
Histopathology
9%
Immunotherapy
13%
In Vivo
8%
Intravenous Immunoglobulin
13%
Lacosamide
9%
Laser Evoked Potential
10%
Magnetic Resonance Imaging
9%
Magnetoencephalography
18%
Motor Neuron Disease
20%
Motor Unit
63%
Muscle Disorder
35%
Muscle Excitability
12%
Muscle Fiber Membrane
23%
Nerve Conduction Study
53%
Nerve Excitability
28%
Nerve Fiber
12%
Neurofilament Light Chain
13%
Neuromuscular Disorder
9%
Neuropathic Pain
11%
Oxaliplatin
19%
Peripheral Nerve
14%
Peripheral Nervous System
10%
Peripheral Neuropathy
40%
Peripheral Neuropathy
8%
Placebo
13%
Plantar Flexors
9%
Polyneuropathy
100%
Quantitative Sensory Testing
9%
Refractory Period
15%
Skeletal Muscle
9%
Somatosensory Evoked Potential
6%
Sural Nerve
17%
Transcranial Magnetic Stimulation
29%
Upper Motor Neuron
9%
